Literature DB >> 8974461

Fatty acid acylated peroxidase as a model for the study of interactions of hydrophobically-modified proteins with mammalian cells.

V I Slepnev1, L Phalente, H Labrousse, N S Melik-Nubarov, V Mayau, B Goud, G Buttin, A V Kabanov.   

Abstract

Artificial fatty acylation of proteins has attracted significant attention during the last decade as a method for modification of protein specificity and efficacy of action on mammalian cells (A. V. Kabanov and V. Yu. Alakhov (1994) J. Contr. Release 28, 15-35). Horse radish peroxidase (HRP) is used in this work to study the interaction of a fatty acylated protein with various mammalian cells. The HRP is modified with the chloranhydride of the stearic acid in the reversed micelles of sodium bis-(2-ethylhexyl)sulfosuccinate (Aerosol OT) in octane, a convenient protocol allowing production of protein molecules with a controlled, low modification degree (A.V. Kabanov et al. (1987) Ann. N. Y. Acad. Sci. 501, 63-66). The influence of the hydrophobic group on the binding and internalization of HRP in MDCK, P3-X63-Ag8, CHO, and HepG2 cells is examined. The major results are as follows: (i) the fatty acylation of a protein significantly enhances its binding to all tested mammalian cell lines, with a line-specific efficiency; (ii) the binding efficiency can be modified by changing growth conditions in a defined medium; (iii) along with the enhancement of protein adsorption on the plasma membrane, fatty acylation increases internalization of the protein during incubations at 37 degrees C; (iv) internalized protein was observed in endocytic vesicles; no evidence was obtained for a cytoplasmic distribution. These results are discussed in connection with previously observed effects of the fatty acylated proteins on cell activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8974461     DOI: 10.1021/bc00035a016

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  7 in total

Review 1.  New technologies for drug delivery across the blood brain barrier.

Authors:  A V Kabanov; E V Batrakova
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

2.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

3.  Protein conjugation with amphiphilic block copolymers for enhanced cellular delivery.

Authors:  Xiang Yi; Elena Batrakova; William A Banks; Serguei Vinogradov; Alexander V Kabanov
Journal:  Bioconjug Chem       Date:  2008-04-16       Impact factor: 4.774

Review 4.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

5.  Protein modification with amphiphilic block copoly(2-oxazoline)s as a new platform for enhanced cellular delivery.

Authors:  Jing Tong; Robert Luxenhofer; Xiang Yi; Rainer Jordan; Alexander V Kabanov
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

6.  Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery.

Authors:  Elena V Batrakova; Serguei V Vinogradov; Sandra M Robinson; Michael L Niehoff; William A Banks; Alexander V Kabanov
Journal:  Bioconjug Chem       Date:  2005 Jul-Aug       Impact factor: 4.774

Review 7.  Brain delivery of proteins via their fatty acid and block copolymer modifications.

Authors:  Xiang Yi; Alexander V Kabanov
Journal:  J Drug Target       Date:  2013-12       Impact factor: 5.121

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.